COMPARATIVE EVALUATION OF TREATMENT PERSISTENCE AND DOSE INTENSIFICATION IN PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB VERSUS VEDOLIZUMAB

Michael Chiorean  1     Jeanne Jiang  2     Ninfa Candela  2     Grace Chen  2     Hela Romdhani  3     Dominick Latremouille-Viau  3     Sherry Shi  3     Rebecca Bungay  4     Tao Fan    
1 Virginia Mason Medical Center,Seattle,United States
2 Takeda Pharmaceuticals,Lexington,United States
3 Analysis Group, Inc,Montreal,Canada
4 Analysis Group, Inc,Montre

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing